Physicians' interactions with pharmaceutical companies
Procopio, L.
Pediatrics 90(2 Part 1): 281-282
1992
ISSN/ISBN: 0031-4005 PMID: 1641301 Document Number: 389559
Document emailed within 1 workday
Related Documents
Nissanholtz-Gannot, R.; Yankellevich, A.; Nirel, N. 2016: The Influence of the Israeli Legislation on the Relationship Between Physicians and Pharmaceutical Companies Harefuah 155(7): 426-430Reis, L.L. 1992: Pharmaceutical companies as sponsors of clinical trials--advantages and limitations Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 333-338
Moon, S. 2005: By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, November 2003 to October 2004 Modern Healthcare 35(1): 32
Hájek, M. 1996: How physicians evaluate the activity of Czech health insurance companies Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 75(1): 3-4
Griffith, J.L. 1994: Limited liability companies: the entity-of-choice is now available for Tennessee physicians Journal of the Tennessee Medical Association 87(10): 439-440
Richardson, M. 1994: Merger mania. Physicians often caught in the middle when health-care companies merge Texas Medicine 90(10): 22-24
Geissbühler, P. 2009: The do-it-yourself pharmaceutical kit for physicians to keep at home Revue Medicale Suisse 5(209): 1440-1441
McKinney, W.P.; Rich, E.C. 2000: Gifts to physicians from the pharmaceutical industry JAMA 283(20): 2656-7; author reply 2657-8
Edwards, D.A. 2000: Gifts to physicians from the pharmaceutical industry JAMA 283(20): 2656; Author Reply 2657-8
Marchetti, M.; Minghetti, P. 1989: Effects of the process of pharmaceutical deregulation on physicians Medicina 9(2): 162-166
Srinonprasert, V.; Arrunyagasamesuke, A.; Nimmannit, A.; Sutheechet, K.; Wongwatcharadeth, P.; Phattharayuttawat, S.; Pongprasobchai, S. 2014: Interaction between physicians and pharmaceutical representatives, an insight from Thailand Journal of the Medical Association of Thailand 97(Suppl 3): S223-S231
Benko, L.B. 2004: From patients to policies. Why do physicians think they can make the jump from running practices to running multibillion-dollar insurance companies? Modern Healthcare 34(45): 41
2011: Conflict of interest regarding clinical physicians'relationship with pharmaceutical industry Seishin Shinkeigaku Zasshi 112(11): 1115-1116
Miyata, Y. 2010: Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education Seishin Shinkeigaku Zasshi 112(11): 1136-1145
Rumboldt, Z.; Mihanović, M. 1979: Awareness of drug interactions among physicians in Split Lijecnicki Vjesnik 101(3): 129-132
Bilodeau, Aèle.; Filion, G.; Labrie, L.; Bouteiller, D.; Perreault, M. 2005: Is it possible to sustain health promotion programs in private companies? The case of four Quebec private companies of blue collar workers Canadian Journal of Public Health 96(2): 114-120
Sáenz Calvo, A.; Ausejo Segura, M.; Cruz Martos, E.; González Alvaro, A.; Pérez Cayuela, P.; Rosado López, A. 1996: Drug-to-drug interactions and pharmaceutical advice Atencion Primaria 17(9): 559-563
Zych, J.; Kostka, V. 1989: The position of the Czech Pharmaceutical Society on problems in the pharmaceutical services during reconstruction of the Czechoslovak health service Ceskoslovenska Farmacie 38(5): 193-194
Pitterle, M.E.; Bond, C.A.; Raehl, C.L. 1992: Pharmaceutical-care index for measuring comprehensive pharmaceutical services American Journal of Hospital Pharmacy 49(9): 2226-2229
Brain, K.R. 1993: The implications of developments in pharmaceutical analysis and new medicines on pharmaceutical education Journal of Pharmacy and Pharmacology 45(Suppl 1): 381-383